Allena Pharmaceuticals, Inc.
-
Ticker
ALNA
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Newton, Massachusetts
Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena’s lead product candidate, reloxaliase, is a first in class, oral enzyme therapeutic for the treatment of hyperoxaluria, a metabolic disorder characterized
…More by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders.
REPORT RATINGS
4.8 / 5.0 (146)
Allena Pharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 146 reviews.
Allena Pharmaceuticals, Inc.
Most Recent Annual Report
MOST RECENT
2021 Annual Report and Form 10K
Older/Archived Annual Reports